Strata Oncology Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 57
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5M
Latest Deal Amount
  • Investors
  • 8

Strata Oncology General Information

Description

Operator of precision oncology company intended to deliver a new standard of care that integrates molecular profiling, decision support, and clinical trial participation into routine practice. The company partners with major healthcare systems across the country, who systematically send their cancer patient's biopsies to high-throughput CLIA lab for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matches to appropriate therapies and drug trials, enabling healthcare providers to provide actionable insight to the lives of cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Primary Office
  • 8192 Jackson Road
  • Suite A
  • Ann Arbor, MI 48103
  • United States
+1 (734) 000-0000

Strata Oncology Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Strata Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 04-Nov-2020 $5M 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 23-May-2018 0000 0000 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 02-Jun-2016 $12M $12M 0000 Completed Startup
To view Strata Oncology’s complete valuation and funding history, request access »

Strata Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Strata Oncology’s complete cap table history, request access »

Strata Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of precision oncology company intended to deliver a new standard of care that integrates molecular profiling, d
Decision/Risk Analysis
Ann Arbor, MI
57 As of 2020
0000
0000000000 0 0000

00000000

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000000
Wuxi, China
00000
00000000000 00000

00000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000000000000
Seattle, WA
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Strata Oncology Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneCast Biotechnology Venture Capital-Backed Wuxi, China 00000 00000000000 00000
00000000 Venture Capital-Backed Seattle, WA 00 0000 000000000 - 0000
0000000 Venture Capital-Backed Houston, TX 000 000.00 0000000000 0 000.00
00000 Venture Capital-Backed New York, NY 00 00000 00000000000 00000
0000000 000000 Private Equity-Backed Vancouver, Canada 00.00 0000000 0000 00.00
You’re viewing 5 of 11 competitors. Get the full list »

Strata Oncology Executive Team (8)

Name Title Board Seat Contact Info
Daniel Rhodes Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Matthew Martin Chief Financial Officer
Catherine Sazdanoff Chief Compliance Officer
Keith Flaherty MD Co-Founder & Board Member
Scott Tomlins Co-Founder & Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Strata Oncology Board Members (8)

Name Representing Role Since
Dan Kidle Arboretum Ventures Board Observer 000 0000
Daniel Rhodes Ph.D Strata Oncology Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Jan Garfinkle Arboretum Ventures Board Member 000 0000
Jeffrey Williams Self Board Member 000 0000
Keith Flaherty MD Strata Oncology Co-Founder & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Strata Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Strata Oncology Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Deerfield Management Venture Capital Minority 000 0000 000000 0
Merck Global Health Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
Renaissance Venture Capital Fund Fund of Funds Minority 000 0000 000000 0
Arboretum Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »